Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Charles S Berkman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Charles S Berkman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:OABI / OmniAb, Inc. Chief Legal Officer 363.212
US:LGND / Ligand Pharmaceuticals Incorporated 23.825
CLO & Secretary, Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Charles S Berkman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Charles S Berkman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-04-07 2025-04-07 4 OABI OmniAb, Inc.
Common Stock
S - Sale -7.206 363.212 -1,95 2,00 -14.412 726.424
2025-04-07 2025-04-07 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13.542 370.418 3,79
2025-02-19 2025-02-19 4 OABI OmniAb, Inc.
Common Stock
S - Sale -7.255 356.876 -1,99 3,67 -26.626 1.309.735
2025-02-19 2025-02-18 4 OABI OmniAb, Inc.
Common Stock
S - Sale -8.215 364.131 -2,21 3,68 -30.231 1.340.002
2025-02-19 2025-02-16 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13.541 372.346 3,77
2025-02-19 2025-02-15 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 15.615 358.805 4,55
2025-01-22 2025-01-21 4 OABI OmniAb, Inc.
Common Stock
S - Sale -25.489 343.190 -6,91 3,24 -82.584 1.111.936
2025-01-22 2025-01-17 4 OABI OmniAb, Inc.
Common Stock
A - Award 45.294 368.679 14,01
2024-12-10 2024-12-09 4 OABI OmniAb, Inc.
Common Stock
S - Sale -8.022 323.385 -2,42 4,13 -33.131 1.335.580
2024-12-10 2024-12-07 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 15.621 331.407 4,95
2024-04-23 2022-11-01 4/A OABI OmniAb, Inc.
Common Stock
A - Award 366.511 305.412 -599,86
2024-04-09 2024-04-08 4 OABI OmniAb, Inc.
Common Stock
S - Sale -6.954 292.617 -2,32 5,27 -36.648 1.542.092
2024-04-09 2024-04-07 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13.541 299.571 4,73
2024-02-20 2024-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -2.034 286.030 -0,71 5,54 -11.268 1.584.606
2024-02-20 2024-02-15 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 5.698 288.064 2,02
2024-02-20 2024-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -5.575 282.366 -1,94 5,54 -30.886 1.564.308
2024-02-20 2024-02-15 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 15.624 287.941 5,74
2024-01-03 2024-01-02 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -7.195 272.317 -2,57 6,25 -44.969 1.701.981
2024-01-03 2024-01-02 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 17.556 279.512 6,70
2023-12-11 2023-12-07 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -5.403 261.956 -2,02 4,85 -26.205 1.270.487
2023-12-11 2023-12-07 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 15.622 267.359 6,21
2023-04-11 2023-04-07 4 OABI OmniAb, Inc.
Common Stock
A - Award 40.625 414.564 10,86
2023-02-17 2023-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -2.166 373.939 -0,58 3,80 -8.231 1.420.968
2023-02-17 2023-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -5.404 376.105 -1,42 3,80 -20.535 1.429.199
2023-02-17 2023-02-15 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -1.973 381.509 -0,51 3,80 -7.497 1.449.734
2023-01-05 2023-01-03 4 OABI OmniAb, Inc.
Common Stock
A - Award 46.864 383.482 13,92
2022-12-30 2022-12-28 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -6.518 336.618 -1,90 3,66 -23.856 1.232.022
2022-12-05 2022-12-01 4 OABI OmniAb, Inc.
Common Stock
F - Taxes -10.580 343.136 -2,99 3,35 -35.443 1.149.506
2022-11-03 2022-11-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -11.944 23.825 -33,39
2022-11-03 2022-11-01 4 NONE OmniAb Operations, Inc.
Common Stock
D - Sale to Issuer -52.587 0 -100,00
2022-11-03 2022-11-01 4 NONE OmniAb Operations, Inc.
Common Stock
A - Award 15.409 52.587 41,45
2022-11-03 2022-11-01 4 OABI OmniAb, Inc.
Common Stock
A - Award 353.716 353.716
2022-06-14 2022-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.375 35.769 17,68
2022-05-09 2022-05-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 20.126 20.126
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -577 30.394 -1,86 123,68 -71.363 3.759.130
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -633 30.971 -2,00 123,68 -78.289 3.830.493
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -368 31.604 -1,15 123,68 -45.514 3.908.783
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.326 31.972 -3,98 113,68 -150.740 3.634.577
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -830 33.298 -2,43 113,68 -94.354 3.785.317
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3.836 34.128 12,66
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.401 30.292 8,61
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -442 27.891 -1,56 172,46 -76.227 4.810.082
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -368 28.333 -1,28 172,46 -63.465 4.886.309
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -205 28.701 -0,71 172,46 -35.354 4.949.774
2021-02-05 2021-02-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -18.097 28.906 -38,50 178,50 -3.230.376 5.159.819
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 6.955 6.955
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3.491 47.003 8,02
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -830 43.512 -1,87 156,01 -129.488 6.788.307
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.401 44.342 5,72
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -509 41.941 -1,20 156,10 -79.455 6.546.990
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1.335 42.450 3,25
2020-07-01 2020-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 238 41.115 0,58 89,03 21.189 3.660.427
2020-06-05 2020-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -11.146 40.877 -21,43 118,59 -1.321.775 4.847.497
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -367 52.023 -0,70 97,23 -35.683 5.058.196
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -207 52.390 -0,39 97,23 -20.127 5.093.880
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -307 52.597 -0,58 97,23 -29.850 5.114.006
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 17.220 17.220
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3.835 52.904 7,82
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -546 49.069 -1,10 105,87 -57.805 5.194.935
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1.335 49.615 2,77
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -585 48.280 -1,20 105,87 -61.934 5.111.404
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1.693 48.865 3,59
2019-08-06 2019-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -424 4.153 -9,26
2019-08-06 2019-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -669 1.948 -25,56
2019-08-06 2019-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 424 47.172 0,91 85,79 36.375 4.046.886
2019-08-06 2019-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 669 46.748 1,45 56,26 37.638 2.630.042
2019-07-02 2019-06-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 182 46.079 0,40 97,03 17.659 4.470.930
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 14.649 14.649
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3.202 45.897 7,50
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1.412 42.695 3,42
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1.370 41.283 3,43
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.931 0 -100,00
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -675 2.617 -20,50
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -244 0 -100,00
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 675 39.913 1,72 56,26 37.976 2.245.505
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.931 39.238 5,18 74,42 143.705 2.920.092
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 244 37.307 0,66 21,92 5.348 817.769
2018-12-17 2018-12-17 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -3.400 244 -93,30
2018-12-17 2018-12-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 3.400 37.063 10,10 21,92 74.528 812.421
2018-10-25 2018-10-24 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -2.688 0 -100,00
2018-10-25 2018-10-24 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.212 3.644 -24,96
2018-10-25 2018-10-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.212 33.663 3,73 21,92 26.567 737.893
2018-10-25 2018-10-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.688 32.451 9,03 14,47 38.895 469.566
2018-10-12 2018-10-11 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -2.000 2.688 -42,66
2018-10-12 2018-10-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.000 29.763 7,20 14,47 28.940 430.671
2018-09-18 2018-09-17 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -2.813 6.830 -29,17
2018-09-18 2018-09-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -2.813 27.763 -9,20 250,69 -705.181 6.959.812
2018-09-18 2018-09-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 2.813 30.576 10,13 100,38 282.369 3.069.219
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -469 0 -100,00
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -5.886 4.577 -56,26
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -5.985 1.931 -75,61
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -7.077 3.292 -68,25
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -19.417 27.763 -41,16 254,99 -4.951.065 7.079.179
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.886 47.180 14,25 85,79 504.960 4.047.572
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 7.077 41.294 20,68 56,26 398.152 2.323.200
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.985 34.217 21,20 74,42 445.404 2.546.429
2018-09-05 2018-09-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 469 28.232 1,69 21,92 10.280 618.845
2018-07-03 2018-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 180 27.763 0,65 117,84 21.210 3.271.467
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -392 27.583 -1,40 165,87 -65.021 4.575.192
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1.136 27.975 4,23
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 9.292 9.292
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1.780 26.839 7,10
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -260 25.059 -1,03 157,18 -40.867 3.938.774
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -252 25.319 -0,99 157,18 -39.609 3.979.640
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -524 25.571 -2,01 157,18 -82.362 4.019.250
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.175 26.095 -4,31 138,66 -162.926 3.618.333
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.847 27.270 11,66
2017-08-10 2017-08-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -18.625 24.423 -43,27 126,96 -2.364.671 3.100.798
2017-07-05 2017-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 243 43.048 0,57 87,12 21.171 3.750.557
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 9.643 9.643
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.259 42.805 5,57
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.619 40.546 6,91
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.295 469 -90,16
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -12.084 7.916 -60,42
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -5.688 10.369 -35,42
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -4.947 0 -100,00
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -3.333 0 -100,00
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 3.333 37.927 9,63 40,86 136.186 1.549.697
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.947 34.594 16,69 42,90 212.226 1.484.083
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -12.084 29.647 -28,96 123,16 -1.488.265 3.651.325
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 12.084 41.731 40,76 74,42 899.291 3.105.621
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5.688 29.647 -16,10 123,16 -700.534 3.651.325
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 5.688 35.335 19,19 56,26 320.007 1.987.947
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.295 29.647 -12,65 123,16 -528.972 3.651.325
2016-08-09 2016-08-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.295 33.942 14,49 21,92 94.146 744.009
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10.463 10.463
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.193 29.647 7,99
2015-07-14 2015-07-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.000 0 -100,00
2015-07-14 2015-07-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.000 27.454 3,78 53,10 53.100 1.457.807
2015-07-14 2015-07-10 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -8.442 4.688 -64,30
2015-07-14 2015-07-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -5.625 0 -100,00
2015-07-14 2015-07-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -2.825 26.454 -9,65 99,86 -282.104 2.641.696
2015-07-14 2015-07-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -8.838 29.279 -23,19 99,18 -876.553 2.903.891
2015-07-14 2015-07-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -2.404 38.117 -5,93 98,15 -235.953 3.741.184
2015-07-14 2015-07-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 8.442 40.521 26,32 14,47 122.156 586.339
2015-07-14 2015-07-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.625 32.079 21,26 10,05 56.531 322.394
2015-07-01 2015-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 465 26.454 1,79 45,67 21.237 1.208.167
2015-03-18 2015-03-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.130 4.764 -46,44
2015-03-18 2015-03-16 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.134 0 -100,00
2015-03-18 2015-03-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.130 25.989 -13,71 74,58 -308.015 1.938.260
2015-03-18 2015-03-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.130 30.119 15,89 21,92 90.530 660.208
2015-03-18 2015-03-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1.134 25.989 -4,18 74,58 -84.574 1.938.260
2015-03-18 2015-03-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.134 27.123 4,36 14,47 16.409 392.470
2015-03-18 2015-03-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6.000 25.989 -18,76 74,51 -447.060 1.936.440
2015-03-18 2014-12-31 4/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 126 27.433 0,46 45,23 5.699 1.240.753
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 16.057 16.057 56,26 903.367 903.367
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 4.556 31.989 16,61
2015-01-05 2014-12-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 126 27.433 0,46 45,23 5.699 1.240.753
2014-07-01 2014-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 329 27.307 1,22 43,79 14.408 1.195.828
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.666 8.894 -15,78
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -347 0 -100,00
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -486 1.134 -30,00
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -486 26.978 -1,77 66,93 -32.528 1.805.638
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 486 27.464 1,80 14,47 7.032 397.404
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1.666 26.978 -5,82 66,93 -111.505 1.805.638
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.666 28.644 6,18 21,92 36.519 627.876
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -347 26.978 -1,27 66,93 -23.225 1.805.638
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 347 27.325 1,29 9,96 3.456 272.157
2014-05-28 2014-05-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.667 26.978 -14,75 66,89 -312.176 1.804.558
2014-02-14 2014-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -2.000 13.130 -13,22
2014-02-14 2014-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2.000 31.645 6,75 14,47 28.940 457.903
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.584 10.560 -30,27
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.166 0 -100,00
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.000 0 -100,00
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.779 0 -100,00
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.736 347 -83,34
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 20.000 20.000 74,42 1.488.400 1.488.400
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -386 4.947 -7,24
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.230 1.620 -43,16
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.736 29.645 6,22 9,96 17.291 295.264
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1.736 27.909 -5,86 74,50 -129.332 2.079.220
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1.230 29.645 -3,98 74,50 -91.635 2.208.552
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.230 30.875 4,15 14,47 17.798 446.761
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.779 29.645 -13,88 74,50 -356.036 2.208.552
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.779 34.424 16,12 10,05 48.029 345.961
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.584 29.645 -13,39 74,50 -341.508 2.208.552
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.584 34.229 15,46 21,92 100.481 750.300
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1.000 29.645 -3,26 74,50 -74.500 2.208.552
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.000 30.645 3,37 16,14 16.140 494.610
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1.166 29.645 -3,78 74,50 -86.867 2.208.552
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.166 30.811 3,93 21,00 24.486 647.031
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -386 29.645 -1,29 74,50 -28.757 2.208.552
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 386 30.031 1,30 42,90 16.559 1.288.330
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.500 29.645 9,21
2014-01-02 2013-12-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 209 27.145 0,78 33,92 7.088 920.623
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -3.834 0 -100,00
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -9.499 3.834 -71,24
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -4.862 0 -100,00
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -11.804 4.862 -70,83
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -7.020 2.850 -71,12
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -312 5.625 -5,26
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 312 26.936 1,17 10,05 3.136 270.707
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.862 26.624 22,34 16,14 78.473 429.711
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 3.834 21.762 21,39 21,00 80.514 457.002
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -7.020 17.928 -28,14 47,54 -333.726 852.285
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7.020 24.948 39,16 14,47 101.579 360.998
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -11.804 17.928 -39,70 47,54 -561.154 852.285
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 11.804 29.732 65,84 16,14 190.517 479.874
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -9.499 17.928 -34,63 47,54 -451.576 852.285
2013-09-04 2013-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 9.499 27.427 52,98 21,00 199.479 575.967
2013-08-20 2013-08-19 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -4.284 5.937 -41,91
2013-08-20 2013-08-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.284 17.928 31,40 10,05 43.054 180.176
2013-08-20 2013-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -14.583 2.083 -87,50
2013-08-20 2013-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -14.583 13.644 -51,66 42,63 -621.732 581.698
2013-08-20 2013-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 14.583 28.227 106,88 9,96 145.247 281.141
2013-07-01 2013-06-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 815 13.644 6,35 17,36 14.148 236.860
2013-05-13 2013-05-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.000 12.829 -23,77 26,66 -106.640 342.021
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15.144 15.144 21,92 331.956 331.956
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 4.856 4.856 21,92 106.444 106.444
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2.500 16.829 17,45
2012-09-10 2012-09-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.249 14.329 -22,87 18,77 -79.754 268.955
2012-07-03 2012-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 1.250 18.578 7,21 10,12 12.654 188.074
2012-03-08 2012-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -106 17.328 -0,61 15,77 -1.671 273.204
2012-03-08 2012-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.500 17.434 -16,72 15,76 -55.160 274.762
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 9.870 9.870 14,47 142.819 142.819
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
A - Award 15.130 15.130 14,47 218.931 218.931
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.000 20.934 31,38
2012-01-06 2011-12-30 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 1.238 15.934 8,42 10,09 12.491 160.766
2007-03-09 3 LGND LIGAND PHARMACEUTICALS INC
Common Stock
1.263
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)